Overexpression of SPINK1 (Serine Peptidase Inhibitor, Kazal type 1) constitutes a substantial ~10–25% of the total PCa cases exclusively in ETS-fusion negative subtype5,6. This evidence concerns the gene SPINK1 and posterior cortical atrophy.